NCT04981223Completed
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
Source: ClinicalTrials.gov · Last updated 28 May 2026
Brief summary (registry, in English)
The goal of this study is to use a clinical micro-ultrasound to systematically image the prostate before biopsy or surgery. The images from the ultrasound system will be saved and compared to other imaging modalities and pathology in order to develop better tools.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 95 (actual)
- First submitted
- 9 Jul 2021
- Start date
- 1 Apr 2022
- Primary completion date
- 26 Jan 2024
- Lead sponsor
- Stanford University
- Diseases
- Prostate cancer
- NCT number
- NCT04981223
What you commit to
- Study type: Interventional
- Participants enrolled: 95
- From 1 Apr 2022 to the primary completion date, 26 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Does not agree to consent.
Who the study is looking for
- Scheduled for MR-US fusion prostate biopsy or radical prostatectomy
- Agree to consent to the study
Age in the registry: 18 years to 89 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Stanford | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.